Navigating an Increasingly Complex Framework to Improve Patient Outcomes With ICI-Based Therapy

Download All
Review multidisciplinary best practices for safely and effectively incorporating immunotherapies into the management of diverse cancers with downloadable slides, a Webcast, expert commentaries, and microlearning opportunities. Then, get individualized recommendations adapted from NCCN Guidelines® for managing immune-related adverse events with a decision support tool.
Marianne Davies, DNP, CNS, ACNP-BC, AOCNP
John L. Marshall, MD

ClinicalThought

Gain new insights on how to leverage tumor mutational burden to select patients most likely to benefit from ICI-based therapy and on ongoing challenges to optimize management of immune-related adverse events.

Marianne Davies, DNP, CNS, ACNP-BC, AOCNP John L. Marshall, MD Released: November 30, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue